Ambarella Inc: Form 10-Q for the period ended Jul 31, 2019
Filed with the SEC on Sep 6, 2019 and accepted by EDGAR at Sep 6, 2019, 13:02 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2019-07-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2019-05-01 to 2019-07-31 | $56.4m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months2019-02-01 to 2019-07-31 | $103.6m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2019-05-01 to 2019-07-31 | $24.0m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months2019-02-01 to 2019-07-31 | $43.3m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2019-05-01 to 2019-07-31 | $32.4m | us-gaap:GrossProfit |
| Gross profit | 6 months2019-02-01 to 2019-07-31 | $60.3m | us-gaap:GrossProfit |
| Research and development | 3 months2019-05-01 to 2019-07-31 | $30.4m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2019-02-01 to 2019-07-31 | $63.4m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2019-05-01 to 2019-07-31 | $12.4m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2019-02-01 to 2019-07-31 | $25.5m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2019-05-01 to 2019-07-31 | −$10.4m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2019-02-01 to 2019-07-31 | −$28.6m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2019-05-01 to 2019-07-31 | $2.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2019-02-01 to 2019-07-31 | $3.2m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2019-05-01 to 2019-07-31 | −$10.2m | us-gaap:NetIncomeLoss |
| Net income | 6 months2019-02-01 to 2019-07-31 | −$27.5m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2019-05-01 to 2019-07-31 | −$0.31 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2019-02-01 to 2019-07-31 | −$0.84 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2019-05-01 to 2019-07-31 | −$0.31 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2019-02-01 to 2019-07-31 | −$0.84 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2019-05-01 to 2019-07-31 | 32,860,974 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2019-02-01 to 2019-07-31 | 32,676,509 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2019-02-01 to 2019-07-31 | $13.4m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2019-02-01 to 2019-07-31 | $954.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 6 months2019-02-01 to 2019-07-31 | $0 | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2019-07-31 | $222.7m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2019-07-31 | $425.6m | us-gaap:AssetsCurrent |
| Total assets | At period end2019-07-31 | $490.2m | us-gaap:Assets |
| Current liabilities | At period end2019-07-31 | $47.2m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2019-07-31 | $61.8m | us-gaap:Liabilities |
| Shareholders' equity | At period end2019-07-31 | $428.5m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001564590-19-034237. Last ingested by Listed: Oct 30, 2026, 13:39 ET. Listed shows no prices and gives no investment advice.